Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

Cellular and Molecular Immunology(2022)10.1038/s41423-021-00809-2Source: DataRank Database

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates is a research paper published in Cellular and Molecular Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 59 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access59 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Topics (29)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Prabhu S. Arunachalam ORCID,Guadalupe Andreani ORCID,Nadia Golden ORCID,Jane Fontenot ORCID,Pyone P. Aye ORCID

Live enrichment

PubMed:34983950 PMC:PMC8727235

NIH HHS

Grant: P51 OD011104

MeSH Terms

AnimalsMacaca mulattaDisease Models, AnimalPolysorbatesSqualenealpha-TocopherolRecombinant ProteinsAdjuvants, ImmunologicAntibodies, ViralDrug CombinationsTreatment OutcomeVaccinationDrug CompoundingMaleImmunity, HumoralAntibodies, NeutralizingVaccines, Virus-Like ParticlePandemicsSpike Glycoprotein, CoronavirusImmunogenicity, VaccineCOVID-19SARS-CoV-2COVID-19 VaccinesNicotiana

Keywords

virus-like particlesAs03Sars-cov-2Cpg1018Non-humane Primates

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

FAIR Checklist

Authors (23)

Funding (1 grants)

Topics

Annotations (Europe PMC)